Communicable Disease Committee

Agreed on plans and measures after Oct. 1, Covid-19 has been adjusted to be a communicable disease that must be monitored.

Patients with mild symptoms - asymptomatic

Separate quarantine for 5 days, cancel showing vaccination certificates - ATK results of immigrants 

On September 21, 2022, Mr. Anutin Charnvirakul, Deputy Prime Minister and Minister of Public Health

Chaired the meeting of the National Communicable Disease Committee No. 7/22, with Dr. Thongchai Lertwilairattanapong

Deputy Permanent Secretary, Ministry of Public Health, MD.

Director-General of the Department of Health Service Support

and committees from various departments participated

Then Mr. Anutin said that the situation of COVID-19

The trend is improving around the world, including Thailand, infected people, patients in treatment, critically ill patients and deaths.

There is a continuous decrease in number

Most of the people are immune from the Covid-19 temple injection.

They cover more than 82% and some are immune from infection.

But there are still elderly people 60 years and over and patients with 7 congenital diseases, a number of diseases that must be asked to receive complete vaccination.

in order to be ready to lead a normal life as much as possible

by modifying various measures

Getting people to live with COVID-19

safely

under balanced consideration

from health, economic, social and security perspectives

Today, the meeting has approved 2 important matters. The first is the approval of the Covid-19 Control Action Plan.

Support for communicable diseases that need to be monitored (October 2022 - September 2023), which has signed a contract to abolish COVID-19

a dangerous contagious disease

and adjusted to be a communicable disease that must be monitored No. 57 in accordance with the Communicable Diseases Act B.E. 2558, which has been announced in the Government Gazette.

Effective from October 1, 2022 onwards with 4 strategies as follows:

1. Defense

Surveillance and disease control

2. Medical and medical treatment

3. Risk communication

public relations

and information information

4. Management, law, society and economy

which will be presented to the Cabinet (Cabinet) for further approval

and requiring all provinces to prepare such action plans to ensure readiness in all aspects

will continue to monitor the situation continuously

If the violence increases

May declare epidemic areas as necessary

As for the second issue, the meeting approved the surveillance measures.

Prevent and control COVID-19

Supporting a contagious disease that must be monitored

• before entering the country

  Cancel showing documents related to vaccine documents or COVID-19 ATK test results,

  except yellow fever that is still operating normally.

• at the international communicable disease control checkpoint

  Canceling random checks of COVID-19 vaccination records

  It continues to monitor travelers with symptoms of dangerous communicable diseases.

  or emerging infectious diseases

• Adjust quarantine measures for mild cases / Covid-19 infected people.

  People who do not show symptoms must strictly follow the DMHT for 5 days

  and advise people to have proper self-protective behaviors such as wearing masks, washing hands, and checking ATK when symptoms are present.

In addition, the meeting also acknowledged 4 other matters as follows:

1. Vaccination Management and Vaccination Plan for COVID-19

(Pfizer scarlet vaccine) in children aged 6 months - 4 years, is expected to start in mid-October 2022 on a voluntary basis for parents and children.

without being a condition of going to school

But it is recommended that all children be vaccinated.

Especially children with underlying medical conditions that are at risk of severe symptoms or death.

2. Guidelines for the use of Long Acting Antibody (LAAB) in Thailand with further improvements

in more than 3,500 people who are immunocompromised

or have been vaccinated

but the immunity does not increase

in order to continue to be immune to COVID-19.

3. Guidelines for medical practice, diagnosis, care and prevention of infection in hospitals

case of COVID-19

after the pandemic

(Post-Pandemic), which the Ministry of Public Health has coordinated with relevant agencies to prepare

so that people can still exercise the same treatment rights as general diseases

both accessing treatment and receiving antiretroviral therapy according to the latest guidelines

including the separation of patients in accordance with the situation in the next phase

4. Chloroquine drug use project

(Chloroquine) to prevent and reduce the spread of Plasmodium Vivax malaria in endemic areas on the Thai-Myanmar border.